About us

FFP Team

Cees Wortel

MD, PhD Chief Medical Officer

Cees Wortel is the founder of Clinquest. With more than 20 years of experience in the development of biopharmaceuticals and innovative medical technologies, Cees has guided Clinquest from a small start-up organization to a successful Healthcare Product Development Service Provider. His experience includes both international academic and industrial pharmaceutical research. He has served as a senior medical research executive for several biopharmaceutical companies, including Centocor, Inc., Repligen Inc., Procept Inc. and Alkermes, Inc. During his tenure at Centocor, Cees was responsible for the development of Remicade®, and at Alkermes, he was responsible for the development of Nutropin DepotTM (in collaboration with Genentech). His industry experience includes the oversight of international medical operations under stringent SOP and GCP standards, and he is internationally recognized for his expertise in the design and analysis of clinical trials. In addition to his industry alliances, Cees serves as a Visiting Associate Professor for the Department of Cardiovascular and Critical Care Medicine at Rush University. Cees trained at the University of Amsterdam, and received his PhD in Immunology in 1993. His academic experience also includes training in the specialties of Cardiology, Hemostasis, Thrombosis, Atherosclerosis and Inflammation Research. He has published widely, presented and chaired many national and international meetings.